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ABSTRACT
Objective To determine the association of non-invasive
cardiacstresstestingbeforeelectiveintermediatetohigh
risk non-cardiac surgery with survival and hospital stay.
Design Population based retrospective cohort study.
Setting Acutecare hospitals in Ontario, Canada,between
1 April 1994 and 31 March 2004.
Participants Patients aged 40 years or older who
underwentspecificelectiveintermediate tohighrisknon-
cardiac surgical procedures.
Interventions Non-invasive cardiac stress testing
performed within six months before surgery.
Main outcome measures Postoperative one year survival
and length of stay in hospital.
Results Of the 271082 patients in the entire cohort,
23991 (8.9%) underwent stress testing. After propensity
scoremethodswereusedtoreduceimportantdifferences
between patients who did or did not undergo
preoperative stress testing and assemble a matched
cohort (n=46120), testing was associated with improved
one year survival (hazard ratio (HR) 0.92, 95% CI 0.86 to
0.99;P=0.03)andreducedmeanhospitalstay(difference
−0.24 days, 95% CI −0.07 to −0.43; P<0.001). In an
analysis of subgroups defined by Revised Cardiac Risk
Index(RCRI)class,testingwasassociatedwithharminlow
riskpatients(RCRI0points:HR1.35,95%CI1.05to1.74),
but with benefit in patients who were at intermediate risk
(RCRI 1-2 points: 0.92, 95% CI 0.85 to 0.99) or high risk
(RCRI 3-6 points: 0.80, 95% CI 0.67 to 0.97).
Conclusions Preoperative non-invasive cardiac stress
testing is associated with improved one year survival and
length of hospital stay in patients undergoing elective
intermediate to high risk non-cardiac surgery. These
benefits principally apply to patients with risk factors for
perioperative cardiac complications.
INTRODUCTION
Every year, approximately 900000 adults worldwide
experiencemajorcardiaccomplicationsaftersurgery,
1
which are associated with increased mortality
2 and
hospitalstay.
3Preoperativenon-invasivecardiacstress
testing may help prevent these complications. This
strategy detects underlying ischaemic heart disease
and identifies individuals who might benefit from
preoperative interventions, aggressive intraoperative
haemodynamic management, closer postoperative
surveillance, or avoiding surgery. Additionally, the
results of stress testing can guide the use of periopera-
tive β blockade, which has greatest benefit in patients
with inducible ischaemia.
4 Given these benefits, the
American College of Cardiology and American
Heart Association guidelines recommend preopera-
tivenon-invasivestresstesting,
5butonlyinindividuals
with clinical risk factors for cardiac complications.
Conversely, some authors have discouraged the use
ofpreoperativestresstesting
6-8becauseitmaydelaysur-
gery and has not been shown to improve postoperative
outcomes. Instead,they advocate routine perioperative
β blockade.
68This recommendation was supported by
the Dutch Echocardiographic Cardiac Risk Evaluation
Applying Stress Echo II (DECREASE II) randomised
trial, which evaluated routine stress testing in inter-
mediate risk patients receiving perioperative β
blockade.
8 The study found no significant effect of pre-
operative stress testing on cardiac complications. None
theless,theestimatedeffecthadawide95%confidence
interval (odds ratio 0.28 to 2.91) that did not exclude
either substantial benefit or harm. Additionally, the
Perioperative Ischemic Evaluation (POISE) trial has
raised concerns about the safety of perioperative β
blockade.
9
Given the potential benefits of preoperative stress
testing but the lack of proved impact on outcomes,
we undertook a population based cohort study of
non-invasivecardiacstresstestinginOntario,Canada.
Our objective was to determine whether stress testing
before major elective non-cardiac surgery was asso-
ciated with improved one year survival and reduced
hospital stay.
METHODS
We used linked population based administrative
healthcaredatabasesinOntario,Canada,toundertake
a retrospective cohort study. The databases used were
the Canadian Institute for Health Information (CIHI)
discharge abstract database, which describes all hospi-
tal admissions; the Ontario Health Insurance Plan
(OHIP) database, which describes physician billing
for inpatient and outpatient services; the Registered
Persons Database (RPDB), which describes
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ders Database (CPDB), which describes physicians’
specialties; the Ontario Drug Benefit (ODB) database,
whichdescribesprescriptionmedicationsdispensedto
all individuals aged older than 65 years; and the 2001
Canadiancensus. Althoughthesedatabaseslack infor-
mation on physiological and laboratory measures (for
example, blood pressure and haemoglobin concentra-
tion), they have been validated for many other out-
comes, exposures, and comorbidities.
10-15 During the
study period, Ontario was Canada’s most populous
province, with approximately 12 million residents
who have access to physician and hospital services
through a universal healthcare programme.
Cohort
Using previously described methods,
16 we retrospec-
tively identified all Ontario residents aged 40 years or
older who underwent one of the following specific
types of elective surgery during fiscal years 1994 to
2003(1 April1994to31March2004):abdominalaor-
tic aneurysm repair; carotid endarterectomy; periph-
eral vascular bypass; total hip replacement; total knee
replacement; large bowel surgery; liver resection;
Whipple procedure; pneumonectomy; pulmonary
lobectomy; gastrectomy; oesophagectomy; nephrect-
omy; or cystectomy. These procedures were selected
because they are intermediate to high risk for perio-
perative cardiac complications,
5 applicable to either
sex, and described in research studies that used the
CIHI database
17-21: procedure codes in the CIHI data-
base have excellent accuracy.
15
Theprincipalexposurewaspreoperativenon-invasive
stress testing, as defined by a physician billing for an out-
patient stress test within 180 days before surgery. These
tests included graded exercise treadmill testing, nuclear
perfusionimaging(exerciseordipyridamolemyocardial
perfusion imaging using sestamibi or thallium as a radio-
tracer,withorwithoutsingle photonemissioncomputed
tomography), and stress (exercise or dobutamine) echo-
cardiography. We used OHIP fee codes and methods
adapted from previous research.
22 The 180 day window
was chosen so that instances where stress testing led to
preoperative coronary revascularisation could be
included—it accounted for a 90 day period between
stress testing and revascularisation
23 and another 90 day
window between revascularisation and surgery.
5
The outcomes of interest were mortality (one year
after surgery) and hospital stay. Mortality was deter-
mined using the CIHI database (in hospital deaths)
and the RPDB (out of hospital deaths). We used the
CIHI database to measure hospital stay.
Demographic information was obtained from the
RPDB. We used validated administrative data
algorithms to identify cases of diabetes and
hypertension.
1114 The OHIP database was used to
identify any patient who required dialysis before the
indexsurgery.Weusedpreviouslydescribedmethods
to identify in the CIHI database the following other
comorbidities from hospital admissions within two
years preceding surgery on the basis of International
Classification of Diseases codes (9th revision, clinical
modification; or 10th revision): ischaemic heart dis-
ease;congestiveheartfailure;cerebrovasculardisease;
pulmonary disease;chronic renal insufficiency; malig-
nancy; liver disease; and dementia.
2425 When identify-
ing comorbidities, only information from acute care
hospital admissions before the index surgery was
used to determine the presence of ischaemic heart dis-
ease, congestive heart failure, cerebrovascular disease,
pulmonary disease, renal insufficiency, and liver dis-
ease.Ourprimaryaimwastoensurethatpostoperative
complications were not misclassified as pre-existing
comorbid diseases.
26 This approach also ensured that
the relevant comorbidity information was almost cer-
tainlyderivedfromdataavailablebeforethepreopera-
tive cardiac stress test.
The OHIP database and the CPDB were used to
identify outpatient consultations (anaesthesiology,
internal medicine, and cardiology) within 60 days
before surgery, echocardiography within 180 days
before surgery,
22 epidural anaesthesia or analgesia
(hereafter referred to as anaesthesia), and intra-
operative invasive monitoring. Procedure codes in
the OHIP database are very accurate.
15 We imputed
patients’ incomes on the basis of their neighbourhood
median income in the 2001 Canadian census.
Tounderstandhownon-invasivestresstestingmight
influence outcomes, we used the OHIP database to
identify related processes of care before surgery—
namely echocardiography, coronary angiography,
percutaneous coronary intervention, and coronary
artery bypass graft surgery—as well as processes of
care after surgery—namely admission to a monitored
bed (critical care unit or step-down unit) and mechan-
ical ventilation. Additionally, the ODB database was
used to identify outpatient prescriptions for β blockers
or statins within 100 days before surgery. We defined
new users of these medications as those who had
prescriptions within 100 days before surgery but no
prescriptions during the period from 180 days to one
year before surgery.
Analyses
AtwotailedPvalueoflessthan0.05wasusedtodefine
statistical significance, and all estimates were calcu-
lated with 95% confidence intervals. Bivariate tests
were initially used to compare the characteristics of
patientswhodidordidnotundergopreoperativestress
testing (t test, Mann-Whitney U test, χ
2 test, Fisher’s
exact test).
We used propensity score methods to adjust for sys-
tematic differences in measured baselinecharacteristics
between the two groups of patients in the study.
2728 A
non-parsimonious multivariable logistic regression
model was developed to estimate a propensity score
for preoperative stress testing. Clinical significance
guided the initial choice of covariates: age; sex; year of
surgery; surgery; income; hospital type (teaching, low
volume non-teaching, moderate volume non-teaching,
or high volume non-teaching); comorbid disease; spe-
cialist consultations (anaesthesiology, general internal
RESEARCH
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phy; epidural anaesthesia; and intraoperative invasive
monitoring.Previouslydescribedmethodswereusedto
categorise non-teaching hospitals into tertiles.
29 We
considered the following comorbid conditions that
were present in at least 1% of the cohort: ischaemic
heart disease; congestive heart failure; cerebrovascular
disease; hypertension; diabetes; pulmonary disease;
renal disease; and malignancy.
We then used a structured iterative approach to
refine this model, with the goal of achieving a balance
of covariates in the matched pairs.
3031 Covariate bal-
ance was measured using the standardised difference,
where an absolute standardised difference above 10%
is suggested to represent meaningful imbalance.
3132
We then matched patients who underwent testing to
those who did not on the basis of a calliper width of
0.2 standard deviations of the log odds of the propen-
sity score. This method involved sampling without
replacement and has been shown to remove 98% of
bias from measured covariates.
33 Within the matched
pairs, we used a stratified Cox proportional hazards
model to compare one year survival.
31 Given that the
interaction term between the exposure (stress testing)
and time was not statistically significant, we were satis-
fied that the model met the proportional hazards
assumption. Other continuous and dichotomous out-
comeswerecomparedusingstatisticalmethodsappro-
priate for paired data.
31
Subgroup analyses were performed on the basis of
ischaemic heart disease, surgical procedure (vascular,
orthopaedic, intraperitoneal, or intrathoracic), and
Revised Cardiac Risk Index (RCRI) class (0 points,
1-2 points, or 3 or more points).
34 The RCRI is com-
posed of six equally weighted clinical risk factors:
ischaemic heart disease; congestive heart failure;
cerebrovascular disease; diabetes; renal insufficiency;
and high risk surgery (intra-abdominal, intrathoracic,
or suprainguinal vascular procedures). For the sub-
group analyses, we repeated the same propensity
score matching process while simultaneously forcing
an exact match on the subgroup characteristics. One
year survival was then compared within the subgroup
specific matched pairs. We used an interaction term in
the Cox model to test for any subgroup effects.
35 An
additional subgroup analysis was performed among
patients older than 66 years to describe preoperative
β blocker and statin use. We used this particular sub-
group because data on outpatient prescriptions are
available only for individuals aged above 65 years in
Ontario.
We conducted several sensitivity analyses to test the
robustness of our results. Firstly, we assessed the influ-
ence ofanalternativematchingmethodonourresults.
The original propensity score was modified to include
an estimate of unmeasured disease burden: the num-
ber of acute care hospital admissions within two years
before surgery. Secondly, we used the CIHI database
to determine the association of preoperative testing
with an outcome where no differences would be
expected, namely surgical site infections. Previous
research suggests that administrative data can identify
surgicalsiteinfectionswithreasonableaccuracy.
36The
purpose of this “tracer” analysis was to assess for
unmeasuredresidualconfounding.Giventhatsurgical
site infections are associated with increased patient
risk
37 but should be unaffected by stress testing, we
hypothesised that testing would not be associated
with increased rates of these complications.
RESULTS
The study cohort consisted of 271082 patients, of
whom 23991 (8.9%) underwent non-invasive stress
testing within 180 days before surgery (tables 1 and
2). Some patients underwent more than one test;
hence, a total of 25877 stress tests were performed.
The median time between testing and surgery was
48 days (interquartile range 16 to 101 days). A total of
7795(30%)ofthesetestswereorderedbycardiologists,
7234 (28%) by internists, 6281 (24%) by family physi-
cians,3594(14%)bysurgeons,477(1.8%)byanaesthe-
siologists, and 496 (1.9%) by other specialists. Of the
patients who underwent preoperative testing, 914
(3.8%) underwent coronary angiography, 149 (0.6%)
underwent percutaneous coronary intervention, and
134(0.6%)underwentcoronaryarterybypassgraftsur-
gery between the dates of stress testing and surgery.
Patients who underwent preoperative testing and
those who did not differed with regard to all measured
characteristics(tables 1and2).Patientswhounderwent
Table 1 |Preoperative characteristics of entire cohort. Values are expressed as number
(percentage) unless indicated otherwise
Stress testing
(n=23 991)
No testing
(n=247 091) P value
Demographics
Female sex 9662 (40.3) 129 645 (52.5) <0.001
Age (years; mean (SD)) 69.1 (9.2) 68.3 (10.3) <0.001
Socioeconomic status
Annualincome(Canadian dollars; mean (SD)) 24 846 (5105) 24 693 (5067) <0.001
Comorbid disease
Ischaemic heart disease 5566 (23.2) 20 996 (8.5) <0.001
Congestive heart failure 1022 (4.3) 6005 (2.4) <0.001
Cerebrovascular disease 1684 (7.0) 10 206 (4.1) <0.001
Hypertension 14 887 (62.1) 130 950 (53.0) <0.001
Diabetes 5881 (24.5) 43 442 (17.6) <0.001
Pulmonary disease 1582 (6.6) 12 425 (5.0) <0.001
Dialysis or renal disease 481 (2.0) 2907 (1.2) <0.001
Malignancy 2265 (9.4%) 21 647 (8.8) 0.004
Specialist consultation*
Anaesthesiology 12 967 (54.0) 91 749 (37.1) <0.001
General internal medicine 5758 (24.0) 57 416 (23.2) 0.008
Cardiology 5828 (24.3) 14 709 (6.0) <0.001
Preoperative cardiac procedure† †
Echocardiogram 10 855 (45.2) 21 113 (8.5) <0.001
Coronary angiogram 1256 (5.2) 1463 (0.6) <0.001
Percutaneous coronary intervention 314 (1.3) 297 (0.1) <0.001
Aorto-coronary bypass surgery 302 (1.3) 525 (0.2) <0.001
*Within 60 days before surgery.
†Within 180 days before surgery.
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volume or moderate volume non-teaching hospital
and had an increased burden of comorbid disease.
They were also more likelytobeevaluated bya specia-
listbeforesurgery,undergopreoperativecardiacproce-
dures, and require intraoperative care such as epidural
anaesthesia or intraoperative invasive monitoring.
Of the patients who underwent stress testing, 23060
(96%) were successfully matched to a similar patient
who did not. The covariate balance between the two
arms was improved considerably by propensity score
matching (tables 3 and 4): the mean standardised dif-
ferencebetweenthetwogroupsdecreasedfrom14.9%
(range 0.3 to 90.9) to 0.48% (0.02 to 1.5). Of the
matched patients who underwent testing, 914 (4.0%)
underwent coronary angiography, 136 (0.6%) under-
went percutaneous coronary intervention, and 119
(0.5%)underwentcoronaryarterybypassgraftsurgery
between the dates of stress testing and surgery.
Within the matched cohort, one year survival was
higher among patients who had undergone preopera-
tive testing than in those who had not (hazard ratio
(HR) 0.92, 95% CI 0.86 to 0.99, P=0.03; fig 1). This
correspondedtoanumberneededtotreat
38toprevent
mortalityat oneyearof221 (95% CI111 to16067). In
hospital mortality and hospital stay were also reduced
among patients who underwent stress testing (relative
risk (RR) 0.85, 95% CI 0.73 to 0.98; P=0.03 and 8.
72 days v 8.96 days, difference −0.24 days, 95% CI
−0.07 to −0.43; P<0.001, respectively; table 5).
Patients who had undergone stress testing were more
likely to be admitted to a monitored bed after surgery
than were those who had not undergone testing (RR
1.09, 95% CI 1.06 to 1.12; P<0.001; table 5). Conver-
sely, rates of postoperative mechanical ventilation
were similar in the two groups (RR 1.02, 95% CI 0.98
to 1.08; P=0.25).
In sensitivity analyses, the association of stress test-
ing with improved one year survival was unaffected
when the number of previous acute care hospital
admissions within two years before the index surgery
was added to the original propensity score (HR 0.92,
95% CI 0.86 to 0.99; P=0.02). Additionally, we found
no statistically significant association between stress
testing and surgical site infections (RR 1.00, 95% CI
0.94 to 1.07; P=0.89; table 5).
Thesubgroupofindividualsolderthan66yearscon-
sisted of 15475 patients who underwent stress testing
and 15475 who did not. In this subgroup, 5626 (36%)
ofthosewhounderwentpreoperativestresstestingand
3998 (26%) of those who did not were receiving β
blockers (RR 1.41, 95% CI 1.36 to 1.45; P<0.001).
Additionally, 1895 (12%) patients who had undergone
testing were new β blocker users, compared with 827
(5.3%) who had not undergone testing (RR 2.23, 95%
CI 2.12 to 2.48; P<0.001). More patients in the stress
testing group were receiving statins (5000 (32%)) than
were those who had not been tested (3679 (24%); RR
1.36, 95% CI 1.31 to 1.41; P<0.001). A total of 974
(6.3%) patients who had undergone testing were new
statin users, comparedwith 539 (3.5%) of patients who
had not (RR 1.81, 95% CI 1.63 to 2.00; P<0.001).
The association of stress testing with mortality was
unchanged when the analyses were repeated in sub-
groups defined by procedure type (P=0.28 for inter-
action; fig 2). Conversely, the effects of testing on
mortality varied with RCRI class (P=0.005) and, to a
degree, ischaemic heart disease (P=0.08). Preoperative
stress testing was associated with harm in low risk
patients (RCRI 0 points: HR 1.35, 95% CI 1.05 to
1.74);however,itwasassociatedwithimprovedsurvival
in intermediate risk patients (RCRI 1-2 points: HR 0.92,
95% CI 0.85 to 0.99) and high risk patients (RCRI 3-6
points:HR0.80,95%CI0.67to0.97;fig2).Thesediffer-
ences corresponded to a number needed to treat to pre-
vent mortality at one year of 156 for intermediate risk
patients(95%CI79to6127)and38forhighriskpatients
(95% CI 21 to 315). Conversely, the number needed to
harm in low risk patients was 179 (95% CI 97 to 1090).
The relative rates of intervention use (that is, preopera-
tive medications and cardiac procedures) were higher in
low risk patients who underwent stress testing than in
intermediate or high risk patients who were tested (web
table A). The characteristics of the subgroups defined by
RCRI class are presented in web table B.
DISCUSSION
In this population based retrospective cohort study,
non-invasivecardiacstresstestingbeforeelectiveinter-
mediate to high risk non-cardiac surgery was asso-
ciated with improved one year survival and reduced
hospitalstay.Thesebenefitslargelyappliedtopatients
Table 2 |Perioperative characteristics of entire cohort. Values are expressed as number
(percentage) unless otherwise indicated
Stress testing
(n=23 991)
No testing
(n=247 091) P value
Hospital type
Teaching 7759 (32.3) 84 786 (34.3)
<0.001
High volume non-teaching 5951 (24.8) 51 582 (20.9)
Moderate volume non-teaching 5747 (24.0) 54 418 (22.0)
Low volume non-teaching 4534 (18.9) 56 305 (22.8)
Procedure
Abdominal aortic aneurysm repair 2651 (11.0) 5280 (2.1)
<0.001
Carotid endarterectomy 2001 (8.3) 10 044 (4.1)
Peripheral vascular bypass 2579 (10.7) 13 467 (5.5)
Total hip replacement 4020 (16.8) 60 671 (24.6)
Total knee replacement 5694 (23.7) 80 771 (32.7)
Large bowel surgery 3363 (14.0) 50 497 (20.4)
Liver resection 273 (1.1) 1661 (0.7)
Whipple procedure 76 (0.3) 1030 (0.4)
Pneumonectomy or lobectomy 1560 (6.5) 8709 (3.5)
Gastrectomy or oesophagectomy 623 (2.6) 5004 (2.0)
Nephrectomy 957 (4.0) 7900 (3.2)
Cystectomy 194 (0.8) 2057 (0.8)
Intraoperative care
Epidural anaesthesia 7433 (31.0) 49 593 (20.1) <0.001
Arterial line 11 160 (46.5) 70 148 (28.3) <0.001
Central venous line 3288 (13.7) 18 883 (7.6) <0.001
Pulmonary artery catheter 2270 (9.5) 6743 (2.7) <0.001
RESEARCH
page 4 of 9 BMJ | ONLINE FIRST | bmj.comwho were at high risk for cardiac complications on the
basis of three or more clinical risk factors. In contrast,
stress testing was associated with only minor benefits
forintermediateriskpatients(1-2riskfactors)andwith
harm in low risk individuals.
Our results suggest that preoperative stress testing
shouldbereservedforpatientswithclinicalriskfactors
for cardiac complications. In high risk patients with
three or more clinical risk factors, the use of preopera-
tivestresstestingwassupportedbyanassociatedmod-
erateimprovementinoneyearsurvivalandfavourable
number needed to treat. Conversely, in intermediate
riskpatientswithoneortwoclinicalriskfactors,testing
was associated with a small, albeit statistically signifi-
cant, benefit. Given the small magnitude of this effect
and the associated relatively large number needed to
treat, routine preoperative stress testing is not justified
in intermediate risk patients. Our results do, however,
support the safety and potential benefits of selective
testing in intermediate risk patients. Future research
should therefore determine whether stress testing pro-
videsadditionalprognosticinformationinspecificsub-
groups of intermediate risk patients; for example, in
subgroups defined by risk factors that were not cap-
tured by administrative data ( such as poor functional
status) or were suggested by our subgroup analyses
(such as previous history of ischaemic heart disease).
Our study does not support the use of preoperative
stress testing in low risk patients; furthermore, the
resultssuggestthatsuchtestingisassociatedwithharm.
Ourresultsarelargelyconsistentwiththepositionof
the American College of Cardiology and American
Heart Association guidelines, which emphasise stress
testing specifically in individuals who are undergoing
intermediatetohighrisksurgeryandhaveoneormore
clinical risk factors (for example, ischaemic heart dis-
ease, congestive heart failure, cerebrovascular disease,
diabetes,orrenalinsufficiency).
5Theseguidelinesalso
suggest, however, that testing be restricted to indivi-
duals who concurrently have poor or unknown func-
tional capacity. As described above, our data sources
didnotcaptureinformationonexercisetolerance;con-
sequently, further research is needed to determine
whether the prognostic significance of preoperative
stress testing in intermediate to high risk surgical
patients varies with their functional capacity.
Table 3 |Preoperative characteristics of the propensity matched pairs. Values are expressed as number (percentage) unless
otherwise indicated
Stress testing
(n=23 060)
No stress testing
(n=23 060)
Absolute standardised difference
Before matching After matching
Demographics
Female sex 13 572 (58.9) 13 623 (59.1) 24.6% 0.4%
Age (years; mean (SD)) 69.2 (9.2) 69.2 (9.2) 7.6% <0.1%
Socioeconomic status
Annual income (Canadian dollars; mean (SD)) 24 837 (5104) 24 810 (5155) 3.0% 0.5%
Comorbid disease
Ischaemic heart disease 5272 (22.9) 5343 (23.2) 41.1% 0.7%
Congestive heart failure 1011 (4.4) 1018 (4.4) 10.2% 0.1%
Cerebrovascular disease 1638 (7.1) 1661 (7.2) 12.6% 0.4%
Hypertension 14 355 (62.3) 14 381 (62.4) 18.4% 0.2%
Diabetes 5655 (24.5) 5572 (24.2) 17.1% 0.8%
Pulmonary disease 1528 (6.6) 1562 (6.8) 6.7% 0.6%
Dialysis or renal disease 463 (2.0) 458 (2.0) 6.6% 0.2%
Malignancy 2185 (9.5) 2210 (9.6) 2.4% 0.4%
Specialist consultation*
Anaesthesiology 12 299 (53.3) 12 279 (53.2) 34.4% 0.2%
General internal medicine 5670 (24.6) 5804 (25.2) 1.8% 1.3%
Cardiology 5084 (22.0) 4941 (21.4) 53.0% 1.5%
Preoperative cardiac procedure† †
Echocardiogram 9948 (43.1) 9909 (43.0) 90.9% 0.3%
*Within 60 days before surgery.
†Within 180 days before surgery.
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Fig 1 | Survival curves for postoperative all cause mortality in
patients who did (n=23060) or did not (n=23060) undergo
preoperative stress testing (matched by propensity score)
over one year after surgery
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in intermediate to high risk patientsare likely to be the
resultofareductioninperioperativecardiaccomplica-
tions. Prevention of such complications would be ex-
pectedtoimprovebothlengthofhospitalstay
3andone
year survival.
2 By comparison, testing was not asso-
ciated with any difference in the risk of surgical site
infections.
Several plausible mechanisms might, in combina-
tion, explain a reduction in cardiac complications
among individuals who underwent stress testing.
Firstly, the results of preoperative stress testing can
help guide perioperative drug therapy with β blockers
orstatins.βblockadeacrossa broadspectrumofsurgi-
calpatientsmaycauseharm,
9butithasbeenassociated
with strong benefits in patients with multiple clinical
risk factors,
39 especially in those with inducible
ischaemia.
4 Thus, preoperative stress testing may
help identify subgroups of patients that would benefit
from β blocker therapy. Similarly, evidence of ischae-
mic heart disease on preoperative testing may indicate
thatapatientrequiresstatintherapy,whichisalsoasso-
ciated with improved postoperative outcomes.
40
Secondly,clinicianscoulduse preoperativetestingto
determine which patients warrant closer postoperative
surveillance.Thishypothesisissupportedbythehigher
rate of postoperative admission to monitored beds
amongpatientswhohadundergonestresstestingbefore
surgery.Thirdly,stresstestingcanidentifypatientswith
highriskischaemicheartdiseasewhomeetusualindica-
tions for revascularisation
5 or who would benefit from
avoiding surgery. Finally, clinicians might use the
results of preoperative testing to determine which
patients require more aggressive clinical care, such as
stringent haemodynamic management.
In contrast to these benefits for intermediate to high
riskpatients,wefoundthatstresstestingwasassociated
withharminlowriskpatients.Theincreasedmortality
observed might be explained by the use of unneces-
sary, and potentially deleterious, interventions such
as β blockade.
939 It is noteworthy that the frequency
of new β blocker use in low risk patients was 2.8 times
higherinthosewhoweretestedthaninthosewhowere
not (web table A).
Comparison with other studies
Our study warrantscomparison with the DECREASE
II trial,
8 in which 770 patients with one or two clinical
risk factors were randomly allocated to either stress
testing or no testing before major vascular surgery.
Although the rates of cardiac death or myocardial
infarction at 30 days after surgery did not significantly
differ between the two strategies, the few outcome
events (n=16) and wide 95% confidence interval
(oddsratio0.28to2.91)suggestthatthetrialwasunder-
powered to detect a plausible treatment effect. Indeed,
this confidence interval is still consistent with our find-
ing of a small benefit for intermediate risk patients.
Additionally, the design of the DECREASE II trial
might have minimised its ability to detect differences
betweenthestudyarms.Allparticipantsreceivedperi-
operative β blockade and similar postoperative
Table 4 |Perioperative characteristics of the propensity matched pairs. Values are expressed as number (percentage) unless
otherwise indicated
Stress testing
(n=23 060)
No stress testing
(n=23 060)
Absolute standardised difference
Before matching After matching
Hospital type
Teaching 7647 (33.2) 7645 (33.2) 4.2% <0.1%
High volume non-teaching 5618 (24.4) 5639 (24.5) 9.4% 0.2%
Moderate volume non-teaching 5432 (23.6) 5336 (23.1) 4.6% 0.9%
Low volume non-teaching 4363 (18.9) 4440 (19.3) 9.6% 0.8%
Procedure
Abdominal aortic aneurysm repair 2247 (9.7) 2262 (9.8) 36.5% 0.2%
Carotid endarterectomy 1954 (8.5) 1914 (8.3) 17.8% 0.6%
Peripheral vascular bypass 2384 (10.3) 2393 (10.4) 19.5% 0.1%
Total hip replacement 4011 (17.4) 4043 (17.5) 19.4% 0.4%
Total knee replacement 5632 (24.4) 5682 (24.6) 20.0% 0.5%
Large bowel surgery 3276 (14.2) 3282 (14.2) 17.1% <0.1%
Liver resection 272 (1.2) 294 (1.3) 4.9% 0.9%
Whipple procedure 68 (0.3) 57 (0.2) 1.7% 0.9%
Pneumonectomy or lobectomy 1460 (6.3) 1431 (6.2) 13.7% 0.5%
Gastrectomy or oesophagectomy 609 (2.6) 589 (2.6) 3.8% 0.5%
Nephrectomy 917 (4.0) 975 (4.2) 4.3% 1.3%
Cystectomy 180 (0.8) 188 (0.8) 0.3% 0.4%
Intraoperative care
Epidural anaesthesia 6895 (29.9) 6842 (29.7) 25.2% 0.5%
Arterial line 10 497 (45.5) 10 577 (45.9) 38.1% 0.7%
Central venous line 3000 (13.0) 3009 (13.0) 19.7% 0.1%
Pulmonary artery catheter 2037 (8.8) 2070 (9.0) 28.4% 0.5%
RESEARCH
page 6 of 9 BMJ | ONLINE FIRST | bmj.comsurveillance, thereby diminishing the influence of test-
ing on clinical care. Stress testing altered subsequent
management only in that patients with extensive
ischaemia were considered for preoperative revascu-
larisation, which has not been shown to improve
outcomes.
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Strengths and limitations of study
Our study has several strengths. Previous studies eval-
uated the diagnostic accuracy of preoperative stress
testing,
4344 whereas our study focused on the clinically
relevant question of whether it influences outcomes.
Additionally,thelargesamplesizeenabledustodetect
small treatment effects that would have been deemed
non-significant in smaller studies. The population
basedsampleweuseddescribestheeffectsofpreopera-
tive stress testing in “real world” clinical care, as
opposed to in a protocol driven randomised trial.
Thus, our findings can be generalised to other health-
care systems reasonably similar to that in Ontario,
Canada. Finally, our study included only patients
scheduled for elective intermediate to high risk sur-
gery. Urgent or emergency procedures are unlikely
to be delayed to facilitate preoperative stress testing,
whereas patients undergoing low risk ambulatory sur-
geryhave a verylow riskof majorcomplications
45and
are unlikelytobenefitfrompreoperative stresstesting.
Our study, therefore, focused on individuals who had
reasonable opportunities to undergo, and potentially
benefit from, preoperative stress testing.
Our study also has several limitations. Firstly, we
could not compare outcomes from different stress
tests (for example, exercise treadmill testing and
nuclear perfusion). The American College of Cardio-
logy and American Heart Association guidelines
recommend exercise electrocardiography testing as
the test of choice, with the use of other modalities on
the basis of factors such as resting electrocardiogram
abnormalities, patient physique or build, and function
tolerance.
5Giventhat thesefactors arenot recordedin
administrative databases, yet might be prognostically
important,comparisononthebasisoftestingmodality
would be biased by residual confounding.
Secondly, our study was observational in design;
hence, our results demonstrate an association between
preoperative testing and survival, but do not prove
causation. None the less, randomised trials of preo-
perative stress testing also have limitations. A trial of
stress testing in intermediate risk patients would prob-
ably not be feasible. On the basis of the one year mor-
tality rate of approximately 8.9% among intermediate
risk patients in our study, roughly 31100 participants
would be required to detect a 10% relative risk reduc-
tioninarandomisedtrial(twotailedαof0.05and80%
power). Conversely, a randomised trial in high risk
participants would also be large, but potentially feasi-
ble. On the basis of the 15.5% one year mortality rate
among high risk participants in our study, approxi-
mately 4000 high risk individuals would be required
to detect a 20% relative risk reduction (two tailed α of
0.05 and 80% power).
Thirdly,ourdatasourcescouldnot accountforindi-
viduals who underwent preoperative coronary revas-
cularisation on the basis of high risk findings on
preoperative stress testing but subsequently died
before their planned non-cardiac surgeries. These
deaths before surgery are unlikely to affect our results
significantly. In the stress testing arm of the cohort
matched by propensity scores, 335 (1.1%) individuals
subsequentlyunderwenteitherpercutaneouscoronary
intervention or coronary artery bypass graft surgery
before the planned non-cardiac procedures. If the
mortality rate associated with preoperative coronary
revascularisationisassumedtobe2%,
414246sevenindi-
viduals may have undergone stress testing and revas-
cularisation but died before their planned non-cardiac
surgeries. These individuals would have been missing
from our matched cohort, which included only
patients who actually underwent non-cardiac surgery.
None the less, even if these seven missing deaths were
included in our analyses, the proportion of patients
deadatoneyearinthestresstestingarmofthematched
Table 5 |Processes of care and outcomes in the propensity matched pairs. Values are
expressed as number (percentage) unless otherwise indicated
Stress testing
(n=23 060)
No stress testing
(n=23 060)
Difference
(95% CI)
Preoperative cardiac procedure*
Coronary angiogram 1139 (4.9) 549 (2.4) RR 2.08 (1.88 to 2.92)
Percutaneous coronary intervention 288 (1.2) 132 (0.6) RR 2.18 (1.78 to 2.68)
Aorto-coronary bypass surgery 267 (1.2) 213 (0.9) RR 1.25 (1.05 to 1.50)
Postoperative care† †
Admission to a monitored bed 6175 (26.8) 5682 (24.6) RR 1.09 (1.06 to 1.12)
Mechanical ventilation 2672 (11.6) 2596 (11.3) RR 1.02 (0.98 to 1.08)
Outcome
One year mortality 1622 (7.0) 1738 (7.5) HR 0.92 (0.86 to 0.99)
In-hospital postoperative death 310 (1.3) 366 (1.6) RR 0.85 (0.73 to 0.98)
Surgical site infection 1815 (7.9) 1807 (7.8) RR 1.00 (0.94 to 1.07)
Abbreviations: HR, hazard ratio; RR, relative risk.
*Within 180 days before surgery.
†Within 5 days after surgery.
Surgical procedure
  Overall effect
  Intra-abdominal or intrathoracic surgery
  Orthopaedic surgery
  Vascular surgery
History of ischaemic heart disease
  Ischaemic heart disease
  No ischaemic heart disease
Revised Cardiac Risk Index class
  0 points
  1-2 points
  3-6 points
0.92 (0.86 to 0.99)
0.88 (0.81 to 0.97)
1.01 (0.84 to 1.22)
0.99 (0.86 to 1.14)
0.83 (0.72 to 0.96)
0.96 (0.89 to 1.05)
1.35 (1.05 to 1.74)
0.92 (0.85 to 0.99)
0.80 (0.67 to 0.97)
0.6 0.8 1.2 1.0 1.4 1.6 1.8
Hazard ratio
(95% CI)
Hazard ratio
(95% CI)
Fig 2 | Association of preoperative stress testing with one year survival in the subgroup
analyses. The dashed vertical line represents the overall treatment effect (hazard ratio 0.92)
and the solid vertical line represents a null effect (hazard ratio 1)
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Thecorrespondingdifferenceinabsoluteriskbetween
the stress testing and no testing arms would also have
changed negligibly, from 0.50% to 0.47%.
Finally,theadministrativehealthcaredatabasesused
as data sources in our study have inherent limitations.
The data in such databases do not adequately capture
many postoperative complications,
47 causes of death,
detailed clinical information, and some processes of
care (for example, inpatient medications). Such infor-
mationmayhavehelpedtobetterdescribehowtesting
mightalteroutcomes.Futureresearchonpreoperative
stress testing should therefore include more detailed
measurements of such variables (for example, stress
test results and in-hospital medications). Additionally,
these administrative data were not originally collected
forresearchpurposesandmaythereforebesusceptible
to random miscoding. However, the data are very
accurate with respect to describing patient
demographics,
15 hospital stay,
1215 mortality,
1215
procedures,
1215 and physician services.
48 Given that
information on medical comorbidities can be of vari-
able accuracy, we used definitions with generally high
specificity and moderate to good sensitivity.
10-1214 We
further improved the sensitivity of the information by
using hospital admissions information from the two
years preceding surgery.
13 Despite these limitations,
administrative data also offer important advantages of
verylargesamplesizes,systematicdatacollection,and
populationbasedinformationfree fromreferralbias.
48
Conclusions
Non-invasive cardiac stress testing before elective
intermediate to high risk non-cardiac surgery is asso-
ciated with improved one year survival and reduced
hospital stay. These benefits principally apply to
patients at high risk for cardiac complications on the
basis of clinical risk factors. Our results are generally
supportiveofthecurrentAmericanCollegeofCardio-
logy and American Heart Association guidelines for
preoperative cardiac evaluation.
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